Olivier Dewit

Statistics

Publications

Citations

6.8K

H-Index

Active since

1987

Affiliations

Cliniques Universitaires Saint-Luc(Current)

Centre Hospitalier Universitaire de Liège

KU Leuven

University of Liège

Erasmus Hospital

Olivier Dewit is an author at Cliniques Universitaires Saint-Luc specializing in inflammatory bowel disease, inflammatory bowel disease therapy, and pharmacotherapy.

ORCID

Publications per year

1987–2024

Publications

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

David Laharie, Arnaud Bourreille, Julien Branche et al. · The Lancet · 2012 · 642 citations

Pharmacy, Internal Medicine, Pharmacotherapy +14

Novel Crohn Disease Locus Identified by Genome-Wide Association Maps to a Gene Desert on 5p13.1 and Modulates Expression of PTGER4

Cécile Libioulle, Édouard Louis, Sarah Hansoul et al. · PLoS Genetics · 2007 · 563 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study

Brian G. Feagan, William J. Sandborn, Geert D’Haens et al. · The Lancet · 2017 · 446 citations · Full text

Life Sciences, Immunology, Pharmacology +16

The impact of interface usability on trust in Web retailers

Marie Christine Roy, Olivier Dewit, Benoit A. Aubert · Internet Research · 2001 · 393 citations

Business, Information Systems, Management Information Systems +15

Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection

Miguel Regueiro, Brian G. Feagan, Bin Zou et al. · Gastroenterology · 2016 · 329 citations · Full text

Medicine, Clinical Sciences, Surgery +14

1–5 of 65